The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Exome Sequencing-Global Market Insights and Sales Trends 2025
Synopsis
The global Exome Sequencing market size is expected to reach US$ 406.4 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Exome Sequencing in various end use industries. The expanding demands from the Mendelian disease and rare syndrome gene discovery, The research of complex diseases and Mouse exome sequencing,, are propelling Exome Sequencing market. Agilent HaloPlex, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agilent SureSelect segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Exome Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Exome Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exome Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exome Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exome Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exome Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exome Sequencing covered in this report include Illumina TruSeq Exome, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen and BGI, etc.
The global Exome Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina TruSeq Exome
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Global Exome Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exome Sequencing market, Segment by Type:
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Global Exome Sequencing market, by Application
Mendelian disease and rare syndrome gene discovery
The research of complex diseases
Mouse exome sequencing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exome Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Exome Sequencing market size is expected to reach US$ 406.4 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Exome Sequencing in various end use industries. The expanding demands from the Mendelian disease and rare syndrome gene discovery, The research of complex diseases and Mouse exome sequencing,, are propelling Exome Sequencing market. Agilent HaloPlex, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agilent SureSelect segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Exome Sequencing market, driven by demand from China, the second largest economy with some signs of stabilising, the Exome Sequencing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exome Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exome Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exome Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exome Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exome Sequencing covered in this report include Illumina TruSeq Exome, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen and BGI, etc.
The global Exome Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina TruSeq Exome
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Global Exome Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exome Sequencing market, Segment by Type:
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Global Exome Sequencing market, by Application
Mendelian disease and rare syndrome gene discovery
The research of complex diseases
Mouse exome sequencing
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exome Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Exome Sequencing
1.1 Exome Sequencing Market Overview
1.1.1 Exome Sequencing Product Scope
1.1.2 Exome Sequencing Market Status and Outlook
1.2 Global Exome Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Exome Sequencing Market Size by Region (2018-2029)
1.4 Global Exome Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Exome Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Exome Sequencing Market Size (2018-2029)
1.6.1 North America Exome Sequencing Market Size (2018-2029)
1.6.2 Europe Exome Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Exome Sequencing Market Size (2018-2029)
1.6.4 Latin America Exome Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Exome Sequencing Market Size (2018-2029)
2 Exome Sequencing Market by Type
2.1 Introduction
2.1.1 Agilent HaloPlex
2.1.2 Agilent SureSelect
2.1.3 Agilent SureSelect QXT
2.1.4 Illumina TruSeq Exome
2.1.5 Roche Nimblegen SeqCap
2.1.6 MYcroarray MYbaits
2.2 Global Exome Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Exome Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Exome Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Exome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Exome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Exome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Exome Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Exome Sequencing Revenue Breakdown by Type (2018-2029)
3 Exome Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Mendelian disease and rare syndrome gene discovery
3.1.2 The research of complex diseases
3.1.3 Mouse exome sequencing
3.2 Global Exome Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Exome Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Exome Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Exome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Exome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Exome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Exome Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Exome Sequencing Revenue Breakdown by Application (2018-2029)
4 Exome Sequencing Competition Analysis by Players
4.1 Global Exome Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Exome Sequencing as of 2022)
4.3 Date of Key Players Enter into Exome Sequencing Market
4.4 Global Top Players Exome Sequencing Headquarters and Area Served
4.5 Key Players Exome Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Exome Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina TruSeq Exome
5.1.1 Illumina TruSeq Exome Profile
5.1.2 Illumina TruSeq Exome Main Business
5.1.3 Illumina TruSeq Exome Exome Sequencing Products, Services and Solutions
5.1.4 Illumina TruSeq Exome Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina TruSeq Exome Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Profile
5.2.2 Thermo Fisher Main Business
5.2.3 Thermo Fisher Exome Sequencing Products, Services and Solutions
5.2.4 Thermo Fisher Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Exome Sequencing Products, Services and Solutions
5.3.4 Roche Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 Angilent Recent Developments
5.4 Angilent
5.4.1 Angilent Profile
5.4.2 Angilent Main Business
5.4.3 Angilent Exome Sequencing Products, Services and Solutions
5.4.4 Angilent Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 Angilent Recent Developments
5.5 Eurofins
5.5.1 Eurofins Profile
5.5.2 Eurofins Main Business
5.5.3 Eurofins Exome Sequencing Products, Services and Solutions
5.5.4 Eurofins Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Recent Developments
5.6 Sengenics
5.6.1 Sengenics Profile
5.6.2 Sengenics Main Business
5.6.3 Sengenics Exome Sequencing Products, Services and Solutions
5.6.4 Sengenics Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Sengenics Recent Developments
5.7 Ambry
5.7.1 Ambry Profile
5.7.2 Ambry Main Business
5.7.3 Ambry Exome Sequencing Products, Services and Solutions
5.7.4 Ambry Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Ambry Recent Developments
5.8 Macrogen
5.8.1 Macrogen Profile
5.8.2 Macrogen Main Business
5.8.3 Macrogen Exome Sequencing Products, Services and Solutions
5.8.4 Macrogen Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Macrogen Recent Developments
5.9 BGI
5.9.1 BGI Profile
5.9.2 BGI Main Business
5.9.3 BGI Exome Sequencing Products, Services and Solutions
5.9.4 BGI Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 BGI Recent Developments
5.10 Novo Gene
5.10.1 Novo Gene Profile
5.10.2 Novo Gene Main Business
5.10.3 Novo Gene Exome Sequencing Products, Services and Solutions
5.10.4 Novo Gene Exome Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Novo Gene Recent Developments
6 North America
6.1 North America Exome Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Exome Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Exome Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Exome Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Exome Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Exome Sequencing Market Dynamics
11.1 Exome Sequencing Industry Trends
11.2 Exome Sequencing Market Drivers
11.3 Exome Sequencing Market Challenges
11.4 Exome Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
